The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.
Abstract
To investigate the capacity of the pulmonary vascular bed to acutely vasodilate, we examined in 35 consecutive patients with primary pulmonary hypertension (PPH), the hemodynamic effects of incremental inhalation periods of an air-NO mixture at different concentrations (10, 20, and 40 ppm), and compared them with those of an acute infusion of prostacyclin (PGI2). An individual pulmonary vasodilator response was defined by a fall in total pulmonary resistance (TPR) > or = 30% relative to mean TPR baseline value. Thirteen patients were responders and 22 were nonresponders to both drugs, and they did not significantly differ in overall baseline characteristics except for mean right atrial pressure (p < 0.03). In responders, both drugs produced similar individual vasodilator response. Changes in mean pulmonary arterial pressure and TPR observed during NO and PGI2 were closely correlated (r2 = 0.9, p < 0.001, and r2 = 0.7, p < 0.01, respectively). The vasodilator response to NO was not concentration-related with a maximal effect obtained at 10 ppm. Combination of both drugs did not lead to any additive vasodilator response. Unlike PGI2, NO did not induce any systemic effect, no adverse reaction, but a moderate increase in methemoglobin. Inhaled NO at low dose (10 ppm) appears to be an effective, safe, and reliable substitute for PGI2 in screening for acute pulmonary vasodilator responsiveness during therapeutic assessment of patients with PPH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Primary Pulmonary Hypertension: A National Prospective Study
RICH, S., DANTZKER, D. R., AYRES, S. M., BERGOFSKY, E. H., BRUNDAGE, B. H., DETRE, K. M., FISHMAN, A. P., GOLDRING, R. M., GROVES, B. M., KOERNER, S. K., et al. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-216 · Cited by 2,039
Inhaled Nitric Oxide for the Adult Respiratory Distress Syndrome
Rossaint, R., Falke, K. J., Lopez, F., Slama, K., Pison, U., & Zapol, W. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302113280605 · Cited by 1,811
Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction
Frostell, C., Fratacci, M. D., Wain, J. C., Jones, R., & Zapol, W. M. (1991) · Circulation · doi:10.1161/01.cir.83.6.2038 · Cited by 1,128
Inhaled nitric oxide in persistent pulmonary hypertension of the newborn
ROBERTS, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)92686-a · Cited by 863
Frostell, C. G., Blomqvist, H., Hedenstierna, G., Lundberg, J., & Zapol, W. M. (1993) · Anesthesiology · doi:10.1097/00000542-199303000-00005 · Cited by 458
Inhaled nitric oxide in congenital heart disease.
Roberts, J. D., Lang, P., Bigatello, L. M., Vlahakes, G. J., & Zapol, W. M. (1993) · Circulation · doi:10.1161/01.cir.87.2.447 · Cited by 414
Feedback inhibition of nitric oxide synthase activity by nitric oxide
Assreuy, J., Cunha, F. Q., Liew, F. Y., & Moncada, S. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb12886.x · Cited by 389
Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.
Rubin, L. J., Groves, B. M., Reeves, J. T., Frosolono, M., Handel, F., & Cato, A. E. (1982) · Circulation · doi:10.1161/01.cir.66.2.334 · Cited by 316
Primary pulmonary hypertension and fenfluramine use.
Brenot, F., Herve, P., Petitpretz, P., Parent, F., Duroux, P., & Simonneau, G. (1993) · Heart · doi:10.1136/hrt.70.6.537 · Cited by 251
Self-citationGerlach, H., Pappert, D., Lewandowski, K., Rossaint, R., & Falke, K. J. (1993) · Intensive Care Medicine · doi:10.1007/bf01711084 · Cited by 246
Petitpretz, P., Brenot, F., Azarian, R., Parent, F., Rain, B., Herve, P., & Simonneau, G. (1994) · Circulation · doi:10.1161/01.cir.89.6.2722 · Cited by 240
Self-citationSafety guidelines for use of nitric oxide
Foubert, L. A., Fleming, B., Latimer, R. D., Jonas, M. M., Oduro, A., Borland, C. D. R., & Higenbottam, T. (1992) · The Lancet · doi:10.1016/0140-6736(92)91886-d · Cited by 183
Shimokawa, H., Flavahan, N. A., Lorenz, R. R., & Vanhoutte, P. M. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11756.x · Cited by 161
Adnot, S., Kouyoumdjian, C., Defouilloy, C., Andrivet, P., Sediame, S., Herigault, R. A., & Fratacci, M.-D. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.2.310 · Cited by 157
The case for treatment of selected patients with primary pulmonary hypertension.
Reeves, J. Τ., Groves, B. Μ., & Turkevich, D. (1986) · PubMed · doi:10.1164/arrd.1986.134.2.342 · Cited by 125
Adenosine as a vasodilator in primary pulmonary hypertension.
Morgan, J. M., McCormack, D. G., Griffiths, M., Morgan, C., Barnes, P. J., & Evans, T. W. (1991) · Circulation · doi:10.1161/01.cir.84.3.1145 · Cited by 122
Boulanger, C. M., Schini‐Kerth, V. B., Moncada, S., & Vanhoutte, P. M. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb12105.x · Cited by 96
Inhalation of Nitric Oxide Reduced Pulmonary Hypertension after Cardiac Surgery in a 3.2-kg Infant
Selldén, H., Winberg, P., Gustafsson, L. E., Lundell, B. P. W., Böök, K., & FROSTELL, C. G. (1993) · Anesthesiology · doi:10.1097/00000542-199303000-00021 · Cited by 76
Inhaled Nitric Oxide as a Cause of Selective Pulmonary Vasodilatation in Pulmonary Hypertension
PEPKE-ZABA, J., HIGENBOTTAM, T. W., DINH-XUAN, A. T., STONE, D., & WALLWORK, J. (1992) · Survey of Anesthesiology · doi:10.1097/00132586-199212000-00001 · Cited by 47
Cited by
Primary Pulmonary Hypertension
Rubin, L. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360207 · Cited by 1,726
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension
Sitbon, O., Humbert, M., Nunes, H., Parent, F., Garcia, G., Hervé, P., Rainisio, M., & Simonneau, G. É. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02012-0 · Cited by 1,383
Self-citationLong-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension
Sitbon, O., Humbert, M., Jaïs, X., Ioos, V., Hamid, A. M., Provencher, S., Garcia, G., Parent, F., Hervé, P., & Simonneau, G. (2005) · Circulation · doi:10.1161/circulationaha.104.488486 · Cited by 1,255
Self-citationMedical Therapy For Pulmonary Arterial Hypertension
Badesch, D. B., Abman, S. H., Ahearn, G. S., Barst, R. J., McCrory, D. C., Simonneau, G., & McLaughlin, V. V. (2004) · Chest · doi:10.1378/chest.126.1_suppl.35s · Cited by 829
Self-citationPulmonary–Hepatic vascular Disorders (PHD)
Rodríguez-Roisin, R., Krowka, M. J., Hervé, P., & Fallon, M. B. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00010904 · Cited by 796
Metadata
- Authors
- Sitbon, O., Brenot, F., Denjean, A., Bergeron, A., Parent, F., Azarian, R., Herve, P., Raffestin, B., & Simonneau, G.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-02
- Volume
- 151
- Issue
- 2
- Pages
- 384-389
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2062256657
- Cited by
- 315
- References
- 20
- FWCI
- 15.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.